|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2008-9-1
|
|
pubmed:abstractText |
To evaluatethe efficacy and safety of OxyContin tablets (controlled-release oxycodone hydrochloride: 5, 10, 20, and 40 mg) in relieving moderate to severe cancer pain.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
74 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
46-51
|
|
pubmed:meshHeading |
pubmed-meshheading:18758197-Adult,
pubmed-meshheading:18758197-Aged,
pubmed-meshheading:18758197-Aged, 80 and over,
pubmed-meshheading:18758197-Analgesics, Opioid,
pubmed-meshheading:18758197-Delayed-Action Preparations,
pubmed-meshheading:18758197-Drug Utilization,
pubmed-meshheading:18758197-Female,
pubmed-meshheading:18758197-Humans,
pubmed-meshheading:18758197-Male,
pubmed-meshheading:18758197-Middle Aged,
pubmed-meshheading:18758197-Neoplasms,
pubmed-meshheading:18758197-Oxycodone,
pubmed-meshheading:18758197-Pain,
pubmed-meshheading:18758197-Pain Measurement,
pubmed-meshheading:18758197-Palliative Care,
pubmed-meshheading:18758197-Product Surveillance, Postmarketing,
pubmed-meshheading:18758197-Prospective Studies,
pubmed-meshheading:18758197-Tablets,
pubmed-meshheading:18758197-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
|
|
pubmed:affiliation |
Cancer Center of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China. syyu@tjh.tjmu.edu.cn
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
